felbamate has been researched along with Language Disorders in 1 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
Language Disorders: Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.
Excerpt | Relevance | Reference |
---|---|---|
"Felbamate has demonstrated efficacy against a variety of refractory seizures types, including seizures associated with Lennox-Gastaut syndrome, but postmarketing experience revealed serious idiosyncratic adverse effects that were not observed during clinical trials." | 2.43 | Felbamate: consensus of current clinical experience. ( Faught, E; Leppik, IE; Pellock, JM; Shinnar, S; Zupanc, ML, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pellock, JM | 1 |
Faught, E | 1 |
Leppik, IE | 1 |
Shinnar, S | 1 |
Zupanc, ML | 1 |
1 review available for felbamate and Language Disorders
Article | Year |
---|---|
Felbamate: consensus of current clinical experience.
Topics: Anticonvulsants; Drug Interactions; Drug Therapy, Combination; Epilepsy; Felbamate; Humans; Language | 2006 |